The authors hypothesize that increased levels might be due to re-expression of cTnT in skeletal muscle and may also explain the data of Ille et al. who found elevated cTnT but not cTnI levels in their SMA patients (regardless of disease severity) (17). Here, TNNI3 is linked to proximal spinal muscular atrophy.